A simple method for estimating a 'heparin binding capacity' of human serum

Area of Science:

• Biochemistry
• Clinical Chemistry
• Proteomics

Background:

• Heparin's interaction with serum proteins is crucial in various physiological and pathological processes.
• Quantifying the binding affinity of serum proteins to heparin can provide diagnostic and prognostic information.
• Existing methods for assessing heparin-protein interactions may lack precision or comprehensive scope.

Purpose of the Study:

• To develop and validate a novel method for estimating the heparin binding capacity of human serum.
• To establish a quantitative measure of the affinity between serum proteins and heparin.
• To evaluate this method in normal individuals and patients with cystic fibrosis.

Main Methods:

• Human serum is diluted in a low ionic strength, heparin-containing buffer at pH 5.5.
• Formation of insoluble protein-heparin electrostatic complexes is induced.
• Complexes are collected via centrifugation, and the weight ratio of protein to heparin is determined.

Main Results:

• The method allows for the quantitative determination of the protein:heparin combining ratio in insoluble aggregates.
• This ratio serves as a direct measure of the total heparin-binding capacity of serum proteins.
• The study successfully applied this method to assess serum from normal individuals and cystic fibrosis patients.

Conclusions:

• The developed method provides a reliable way to estimate heparin binding capacity in human serum.
• Alterations in this capacity may indicate the presence of abnormal or altered levels of high-affinity heparin-binding proteins.
• This assay has potential applications in diagnosing and monitoring conditions associated with altered serum protein-heparin interactions, such as cystic fibrosis.